{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:40:09Z","timestamp":1748850009709,"version":"3.41.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00414-016-1365-9","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T09:10:45Z","timestamp":1460020245000},"page":"1519-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Determination of the unbound fraction of R- and S-methadone in human brain"],"prefix":"10.1007","volume":"130","author":[{"given":"Karen M. D.","family":"Holm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Linnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,7]]},"reference":[{"key":"1365_CR1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann P (2002) Interindividual variability of the clinical pharmacokinetics of methadone\u2014implications for the treatment of opioid dependence. Clin Pharmacokinet 41:1153\u20131193. doi: 10.2165\/00003088-200241140-00003","journal-title":"Clin Pharmacokinet"},{"key":"1365_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","volume":"50","author":"DJ Foster","year":"2000","unstructured":"Foster DJ, Somogyi AA, Dyer KR, White JM, Bochner F (2000) Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients. Br J Clin Pharmacol 50:427\u2013440. doi: 10.1046\/j.1365-2125.2000.00272.x","journal-title":"Br J Clin Pharmacol"},{"key":"1365_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000018936","volume":"4","author":"JW Vos de","year":"1998","unstructured":"de Vos JW, Ufkes JG, Kaplan CD, Tursch M, Krause JK, van Wilgenburg H, Woodcock BG, Staib AH (1998) L-Methadone and D, L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations. Eur Addict Res 4:134\u2013141. doi: 10.1159\/000018936","journal-title":"Eur Addict Res"},{"key":"1365_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0024-3205(94)00426-S","volume":"56","author":"K Kristensen","year":"1994","unstructured":"Kristensen K, Christensen CB, Christrup LL (1994) The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56:45\u201350. doi: 10.1016\/0024-3205(94)00426-S","journal-title":"Life Sci"},{"key":"1365_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-59745-318-9_10","volume-title":"Drug testing in alternate biological specimens","author":"T Stimpfl","year":"2008","unstructured":"Stimpfl T (2008) Drugs-of-abuse testing in brain. In: Jenkins AJ (ed) Drug testing in alternate biological specimens, 1st edn. Humana Press, Totowa, pp 157\u2013180","edition":"1"},{"key":"1365_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1517\/17460441.3.6.677","volume":"3","author":"D Li","year":"2008","unstructured":"Li D, Kerns E, Carter G (2008) Strategies to assess blood-brain barrier penetration. Expert Opin Drug Dis 3:677\u2013687. doi: 10.1517\/17460441.3.6.677","journal-title":"Expert Opin Drug Dis"},{"key":"1365_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/dmd.105.007211","volume":"34","author":"A Gupta","year":"2006","unstructured":"Gupta A, Chatelain P, Massingham R, Jonsson EN, Hammarlund-Udenaes M (2006) Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p, u), and K(p, uu). Drug Metab Dispos 34:318\u2013323. doi: 10.1124\/dmd.105.007211","journal-title":"Drug Metab Dispos"},{"key":"1365_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","volume":"173","author":"JS Wang","year":"2004","unstructured":"Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (2004) Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology 173:132\u2013138. doi: 10.1007\/s00213-003-1718-1","journal-title":"Psychopharmacology"},{"key":"1365_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/aps.2015.64","volume":"36","author":"XX Diao","year":"2015","unstructured":"Diao XX, Zhong K, Li XL, Zhong DF, Chen XY (2015) Isomer-selective distribution of 3-n-butylphthalide (NBP) hydroxylated metabolites, 3-hydroxy-NBP and 10-hydroxy-NBP, across the rat blood-brain barrier. Acta Pharmacol Sin 36:1520\u20131527. doi: 10.1038\/aps.2015.64","journal-title":"Acta Pharmacol Sin"},{"key":"1365_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/jps.10453","volume":"92","author":"JW Polli","year":"2003","unstructured":"Polli JW, Baughman TM, Humphreys JE, Jordan KH, Mote AL, Salisbury JA, Tippin TK, Serabjit-Singh CJ (2003) P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. J Pharm Sci 92:2082\u20132089. doi: 10.1002\/jps.10453","journal-title":"J Pharm Sci"},{"key":"1365_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0090-9556(25)08028-6","volume":"11","author":"SJ Liu","year":"1983","unstructured":"Liu SJ, Roerig DL, Wang RIH (1983) Brain and plasma-levels of methadone and their relationships to analgesic activity of methadone in rats. Drug Metab Dispos 11:335\u2013338","journal-title":"Drug Metab Dispos"},{"key":"1365_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mcp.2001.116793","volume":"70","author":"DW Boulton","year":"2001","unstructured":"Boulton DW, Arnaud P, DeVane CL (2001) Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate. Clin Pharmacol Ther 70:48\u201357. doi: 10.1067\/mcp.2001.116793","journal-title":"Clin Pharmacol Ther"},{"key":"1365_CR13","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1016\/0006-2952(73)90199-8","volume":"22","author":"RC Baselt","year":"1973","unstructured":"Baselt RC, Bickel MH (1973) Biliary excretion of methadone by the rat: identification of a para-hydroxylated major metabolite. Biochem Pharmacol 22:3117\u20133120. doi: 10.1016\/0006-2952(73)90199-8","journal-title":"Biochem Pharmacol"},{"key":"1365_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.chroma.2004.08.153","volume":"1073","author":"ME Rodriguez-Rosas","year":"2005","unstructured":"Rodriguez-Rosas ME, Medrano JG, Epstein DH, Moolchan ET, Preston KL, Wainer IW (2005) Determination of total and free concentrations of the enantiomers of methadone and its metabolite (2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine) in human plasma by enantioselective liquid chromatography with mass spectrometric detection. J Chromatogr A 1073:237\u2013248. doi: 10.1016\/j.chroma.2004.08.153","journal-title":"J Chromatogr A"},{"key":"1365_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/clpt.1981.34","volume":"29","author":"MK Romach","year":"1981","unstructured":"Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM (1981) Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther 29:211\u2013217. doi: 10.1038\/clpt.1981.34","journal-title":"Clin Pharmacol Ther"},{"key":"1365_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/clpt.1990.37","volume":"47","author":"CB Eap","year":"1990","unstructured":"Eap CB, Cuendet C, Baumann P (1990) Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein. Clin Pharmacol Ther 47:338\u2013346. doi: 10.1038\/clpt.1990.37","journal-title":"Clin Pharmacol Ther"},{"key":"1365_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000107104","volume":"80","author":"S Crettol","year":"2007","unstructured":"Crettol S, Digon P, Golay KP, Brawand M, Eap CB (2007) In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R, S)-methadone, LAAM and their main metabolites. Pharmacology 80:304\u2013311. doi: 10.1159\/000107104","journal-title":"Pharmacology"},{"key":"1365_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.clinbiochem.2005.09.009","volume":"38","author":"DC Lehotay","year":"2005","unstructured":"Lehotay DC, George S, Etter ML, Graybiel K, Eichhorst JC, Fern B, Wildenboer W, Selby P, Kapur B (2005) Free and bound enantiomers of methadone and its metabolite, EDDP in methadone maintenance treatment: relationship to dosage? Clin Biochem 38:1088\u20131094. doi: 10.1016\/j.clinbiochem.2005.09.009","journal-title":"Clin Biochem"},{"key":"1365_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.drugalcdep.2013.07.00","volume":"133","author":"MK Nielsen","year":"2013","unstructured":"Nielsen MK, Johansen SS, Linnet K (2013) Evaluation of metabolite\/drug ratios in blood and urine as a tool for confirmation of a reduced tolerance in methadone-related deaths in Denmark. Drug Alcohol Depend 133:447\u2013451. doi: 10.1016\/j.drugalcdep.2013.07.00","journal-title":"Drug Alcohol Depend"},{"key":"1365_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1556-4029.12627","volume":"60","author":"KM Holm","year":"2015","unstructured":"Holm KM, Linnet K (2015) Distribution of enantiomers of methadone and its main metabolite EDDP in human tissues and blood of postmortem cases. J Forensic Sci 60:95\u2013101. doi: 10.1111\/1556-4029.12627","journal-title":"J Forensic Sci"},{"key":"1365_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/jat\/bks057","volume":"36","author":"KM Holm","year":"2012","unstructured":"Holm KM, Linnet K (2012) Chiral analysis of methadone and its main metabolite, EDDP, in postmortem brain and blood by automated SPE and liquid chromatography-mass spectrometry. J Anal Toxicol 36:487\u2013496. doi: 10.1093\/jat\/bks057","journal-title":"J Anal Toxicol"},{"key":"1365_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jchromb.2013.09.014","volume":"939","author":"X Diao","year":"2013","unstructured":"Diao X, Ma Z, Lei P, Zhong D, Zhang Y, Chen X (2013) Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry. J Chromatogr B 939:67\u201372. doi: 10.1016\/j.jchromb.2013.09.014","journal-title":"J Chromatogr B"},{"key":"1365_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jchromb.2015.08.020","volume":"1002","author":"T Zhou","year":"2015","unstructured":"Zhou T, Zeng J, Liu S, Zhao T, Wu J, Lai W, He M, Xu B, Qu S, Xu L, Tan W (2015) Study on the determination and chiral inversion of R-salbutamol in human plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B 1002:218\u2013227. doi: 10.1016\/j.jchromb.2015.08.020","journal-title":"J Chromatogr B"},{"key":"1365_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/chromsci\/bms262","volume":"51","author":"I Ali","year":"2013","unstructured":"Ali I, Alam SD, Al-Othman ZA, Farooqi JA (2013) Recent advances in SPE-chiral-HPLC methods for enantiomeric separation of chiral drugs in biological samples. J Chromatogr Sci 51:645\u2013654. doi: 10.1093\/chromsci\/bms262","journal-title":"J Chromatogr Sci"},{"key":"1365_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4155\/bio.09.31","volume":"1","author":"K Liu","year":"2009","unstructured":"Liu K, Zhong D, Chen X (2009) Enantioselective quantification of chiral drugs in human plasma with LC-MS\/MS. Bioanalysis 1:561\u2013576. doi: 10.4155\/bio.09.31","journal-title":"Bioanalysis"},{"key":"1365_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jchromb.2006.05.011","volume":"842","author":"LB Rasmussen","year":"2006","unstructured":"Rasmussen LB, Olsen KH, Johansen SS (2006) Chiral separation and quantification of R\/S-amphetamine, R\/S-methamphetamine, R\/S-MDA, R\/S-MDMA, and R\/S-MDEA in whole blood by GC-EI-MS. J Chromatogr B 842:136\u2013141. doi: 10.1016\/j.jchromb.2006.05.011","journal-title":"J Chromatogr B"},{"key":"1365_CR27","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1021\/jm070375w","volume":"50","author":"H Wan","year":"2007","unstructured":"Wan H, Rehngren M, Giordanetto F, Bergstrom F, Tunek A (2007) High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. J Med Chem 50:4606\u20134615. doi: 10.1021\/jm070375w","journal-title":"J Med Chem"},{"key":"1365_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1124\/dmd.106.012294","volume":"35","author":"JC Kalvass","year":"2007","unstructured":"Kalvass JC, Maurer TS, Pollack GM (2007) Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 35:660\u2013666. doi: 10.1124\/dmd.106.012294","journal-title":"Drug Metab Dispos"},{"key":"1365_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1124\/dmd.108.022814","volume":"37","author":"J Watson","year":"2009","unstructured":"Watson J, Wright S, Lucas A, Clarke KL, Viggers J, Cheetham S, Jeffrey P, Porter R, Read KD (2009) Receptor occupancy and brain free fraction. Drug Metab Dispos 37:753\u2013760. doi: 10.1124\/dmd.108.022814","journal-title":"Drug Metab Dispos"},{"key":"1365_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1124\/jpet.105.092916","volume":"316","author":"SG Summerfield","year":"2006","unstructured":"Summerfield SG, Stevens AJ, Cutler L, del Carmen OM, Hammond B, Tang SP, Hersey A, Spalding DJ, Jeffrey P (2006) Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther 316:1282\u20131290. doi: 10.1124\/jpet.105.092916","journal-title":"J Pharmacol Exp Ther"},{"key":"1365_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/dmd.108.024125","volume":"37","author":"X Liu","year":"2009","unstructured":"Liu X, Van NK, Yeo H, Vilenski O, Weller PE, Worboys PD, Monshouwer M (2009) Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos 37:787\u2013793. doi: 10.1124\/dmd.108.024125","journal-title":"Drug Metab Dispos"},{"key":"1365_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/dmd.110.036095","volume":"39","author":"R Longhi","year":"2011","unstructured":"Longhi R, Corbioli S, Fontana S, Vinco F, Braggio S, Helmdach L, Schiller J, Boriss H (2011) Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug Metab Dispos 39:312\u2013321. doi: 10.1124\/dmd.110.036095","journal-title":"Drug Metab Dispos"},{"key":"1365_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/jps.10332","volume":"92","author":"MJ Banker","year":"2003","unstructured":"Banker MJ, Clark TH, Williams JA (2003) Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. J Pharm Sci 92:967\u2013974. doi: 10.1002\/jps.10332","journal-title":"J Pharm Sci"},{"key":"1365_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/1520-6017(200105)90:5<580::AID-JPS1014>3.0.CO;2-4","volume":"90","author":"I Kariv","year":"2001","unstructured":"Kariv I, Cao H, Oldenburg KR (2001) Development of a high throughput equilibrium dialysis method. J Pharm Sci 90:580\u2013587. doi: 10.1002\/1520-6017(200105)90:5<580::AID-JPS1014>3.0.CO;2-4","journal-title":"J Pharm Sci"},{"key":"1365_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/jps.22452","volume":"100","author":"MJ Zamek-Gliszczynski","year":"2011","unstructured":"Zamek-Gliszczynski MJ, Ruterbories KJ, Ajamie RT, Wickremsinhe ER, Pothuri L, Rao MV, Basavanakatti VN, Pinjari J, Ramanathan VK, Chaudhary AK (2011) Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs. J Pharm Sci 100:2498\u20132507. doi: 10.1002\/jps.22452","journal-title":"J Pharm Sci"},{"key":"1365_CR36","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s00216-012-6670-7","volume":"405","author":"MK Bjork","year":"2013","unstructured":"Bjork MK, Simonsen KW, Andersen DW, Dalsgaard PW, Sigurethardottir SR, Linnet K, Rasmussen BS (2013) Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 405:2607\u20132617. doi: 10.1007\/s00216-012-6670-7","journal-title":"Anal Bioanal Chem"},{"key":"1365_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bdd.325","volume":"23","author":"JC Kalvass","year":"2002","unstructured":"Kalvass JC, Maurer TS (2002) Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos 23:327\u2013338. doi: 10.1002\/bdd.325","journal-title":"Biopharm Drug Dispos"},{"key":"1365_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1124\/dmd.110.035998","volume":"39","author":"M Frid\u00e9n","year":"2011","unstructured":"Frid\u00e9n M, Bergstrom F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U (2011) Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug Metab Dispos 39:353\u2013362. doi: 10.1124\/dmd.110.035998","journal-title":"Drug Metab Dispos"},{"key":"1365_CR39","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1080\/00498250802499459","volume":"38","author":"SG Summerfield","year":"2008","unstructured":"Summerfield SG, Lucas AJ, Porter RA, Jeffrey P, Gunn RN, Read KR, Stevens AJ, Metcalf AC, Osuna MC, Kilford PJ, Passchier J, Ruffo AD (2008) Toward an improved prediction of human in vivo brain penetration. Xenobiotica 38:1518\u20131535. doi: 10.1080\/00498250802499459","journal-title":"Xenobiotica"},{"key":"1365_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1124\/dmd.111.038778","volume":"39","author":"L Di","year":"2011","unstructured":"Di L, Umland JP, Chang G, Huang Y, Lin Z, Scott DO, Troutman MD, Liston TE (2011) Species independence in brain tissue binding using brain homogenates. Drug Metab Dispos 39:1270\u20131277. doi: 10.1124\/dmd.111.038778","journal-title":"Drug Metab Dispos"},{"key":"1365_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1124\/dmd.107.018713","volume":"36","author":"M Gertz","year":"2008","unstructured":"Gertz M, Kilford PJ, Houston JB, Galetin A (2008) Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations. Drug Metab Dispos 36:535\u2013542. doi: 10.1124\/dmd.107.018713","journal-title":"Drug Metab Dispos"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-016-1365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00414-016-1365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-016-1365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-016-1365-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:59:02Z","timestamp":1748847542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00414-016-1365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,7]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1007\/s00414-016-1365-9","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"type":"print","value":"0937-9827"},{"type":"electronic","value":"1437-1596"}],"subject":[],"published":{"date-parts":[[2016,4,7]]}}}